Skip to main content
All lobbying filings

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Lobbying for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 19, 2026
Expenses
$690,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 5
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • Health Resources & Services Administration (HRSA)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 3
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 247
    Health Care Affordability Act of 2025
  • S 46
    Health Care Affordability Act of 2025
 Lobbying activity 5
Pharmacy

340B Program; Issues related to affordable prescription drugs; Equitable Community Access to Pharmacy Services Act; issues related to preventing and mitigating drug shortages;

Budget/Appropriations

H.R. 1, the One Big Beautiful Bill Act; EAPTC Extension

Taxation/Internal Revenue Code

H.R. 247/S. 46, the Healthcare Affordability Act; extending advanced premium tax credits (APTCs); issues related to provider taxes.

Health Issues

Labor Health and Human Services Education, Homeland, Commerce, Justice, Science Appropriations; 340B Program; Issues related to affordable prescription drugs; Issues related to health care workforce and staffing; Issues related to health care privacy; Issues related to telehealth authorities; Issues related to hospital price transparency; Issues related to hospital reimbursement; Issues related to nonprofit hospital practices; Site-neutral payment policy; Issues related to hospital outpatient department payments; Issues related to DSH; Issues related to Medicaid supplemental payments; Issues related to Medicare payments; Issues related to Medicare Advantage reimbursement and prior authorization; Issues related to childrens medical care; issues related to rural health; Issues related to mental and behavioral health; enhanced Advanced Premium Tax Credits; issues related to the implementation of H.R. 1, the One Big Beautiful Bill Act;

Medicare/Medicaid

Labor Health and Human Services Education, Homeland, Commerce, Justice, Science Appropriations; 340B Program; Issues related to affordable prescription drugs; Issues related to health care workforce and staffing; Issues related to health care privacy; Issues related to telehealth authorities; Issues related to hospital price transparency; Issues related to hospital reimbursement; Issues related to nonprofit hospital practices; Site-neutral payment policy; Issues related to hospital outpatient department payments; Issues related to DSH; Issues related to Medicaid supplemental payments;Issues related to Medicare payments; Issues related to Medicare Advantage reimbursement and prior authorization; Issues related to childrens medical care; issues related to rural health; Issues related to mental and behavioral health; enhanced Advanced Premium Tax Credits; issues related to the implementation of H.R. 1, the One Big Beautiful Bill Act;

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem